Silicon Graphics says sales will be flat
Workstation developer Silicon Graphics hit the financial marketswith a one-two punch of bad news late last month. The MountainView, CA, company initiated a replacement program to correct problemsin a high-end computer chip and warned that it expects
Workstation developer Silicon Graphics hit the financial marketswith a one-two punch of bad news late last month. The MountainView, CA, company initiated a replacement program to correct problemsin a high-end computer chip and warned that it expects revenuesto be only slightly higher for its first quarter (end-September).
Silicon Graphics chairman and CEO Edward McCracken said thecompany's sluggish sales were due in part to market anticipationof its new O2 workstation, which was introduced on Monday. McCrackensaid the O2 debut was one of SGI's most important new introductionsin several years.
In addition, SGI last month began a replacement program forcustomers who bought workstations shipped between March and Julywith the MIPS R10000 microprocessor. Systems with the affectedmicroprocessors may shut down, the company said. The R10000 chipis a 64-bit microprocessor that was debuted earlier this year(SCAN 1/31/96). Shipments since Aug. 1 are free of the defect.
SGI expected to post revenues only slightly higher than the$758 million recorded last year (including sales of Cray Research,which has SGI acquired), McCracken said. The company said itsnet income will be below market expectations.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
